Finland· FI-REL-REL21332

Equinasil Comp

A quinapril und diuretika product containing quinapril hydrochloride + hydrochlorothiazide, registered in Finland by Medis Danmark A/S c/o Deloitte. 4W-FI. Larsen. The same ATC class is registered in 5 of our 19 countries.

ATC C09BA06

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedEquinasil CompATCC09BA06REGISTER NO.FI-REL-REL21332PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Quinapril und diuretika is registered in 5 of 19 countries.

Countries holding a registration under ATC C09BA06 (quinapril und diuretika), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 3 of them publish a price we can compare per daily dose

Quinapril und diuretika · ATC C09BA06

5 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Italyprice
  • Netherlands
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Quinapril hydrochloride + Hydrochlorothiazide
Manufacturer
Medis Danmark A/S c/o Deloitte. 4W-FI. Larsen
Country
Finland (FI)
ATC code
C09BA06
ATC class
Quinapril und Diuretika
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

67 interactions on record for quinapril und diuretika.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Quinapril und diuretika · interactions on record

67 records

67 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Quinapril und diuretika in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All quinapril und diuretika products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Germany · Quinaplus, Quinapril/Hydrochlorothiazid Aurobindo
  • Spain · Lidaltrin-Diu
  • France · Acuilix, Quinapril Hydrochlorothiazide Eg
  • Italy · Quinapril E Idroclorotiazide Mylan Generics, Quinapril Idroclorotiazide Aurobindo
  • Netherlands · Quinapril/Hct Cf
  • Sweden · Kinoprilam Comp
  • Slovakia · Stadapress

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b16f4f93-eb70-43ae-aaad-450a10f2b3a6
GET /v1/drugs/b16f4f93-eb70-43ae-aaad-450a10f2b3a6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "1",
  "form": "tabletti, kalvopäällysteinen",
  "route": null,
  "ddd_unit": "ED",
  "strength": "10 mg / 12.5 mg",
  "atc_label": "kinapriili ja diureetit",
  "ma_number": "19388",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL21332",
  "authorised_at": "2005-01-17"
}

See everything about quinapril und diuretika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.